The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
WuXi Biologics, part of WuXi AppTec, a Shanghai, China-headquartered contract service provider, has formed a development and manufacturing pact with Immune Pharmaceuticals, a New York-headquartered clinical-stage biopharmaceutical company focused...
Abzena, a contract manufacturer of biologics and antibody drug conjugates, has signed manufacturing and bioconjugation agreements with Telix Pharmaceuticals, a Melbourne, Australia-based clinical-stage biopharmaceutical company. Telix specializes...
Bain Capital Private Equity, a private investment firm, has agreed to acquire DSM Sinochem Pharmaceuticals (DSP), a Singapore-headquartered producer of antibiotics, statins, and antifungals.
DSP is a 50/50 joint venture of Royal DSM, a life...
Bosch Packaging Technology has announced plans to sell its packaging machinery business.
“After intensively and thoroughly considering all its strategic options, the Bosch Group has decided to look for a buyer for its packaging machinery business...
Boehringer Ingelheim (BI) has completed a new filling line at its commercial manufacturing facility in Shanghai, China for its contract manufacturing business, BioXcellence. The new isolator-based fill/finish line is for GMP operations for aseptic...
Catalent has agreed to acquire Juniper Pharmaceuticals, a Boston, Massachusetts-headquartered specialty pharmaceutical company with contract development and manufacturing services, including its Nottingham, UK-based Juniper Pharma Services...
General Electric (GE) has announced plans to spin off GE Healthcare, its healthcare business, as a stand-alone company, following results from a strategic review. The plan is part of a larger reorganization and strategic alignment of the company....
WuXi Biologics, part of WuXi AppTec, a Shanghai, China-headquartered contract service provider, has begun construction of an antibody-drug conjugate (ADC) service center in Wuxi, China.
The $20-million 6,000-square-meter facility will be...
MilliporeSigma has signed an agreement with HistoCyte Laboratories, a Tyne, UK-based cell-line technology company, to be the exclusive multinational distributor of HistoCyte’s portfolio of cell-line reference products for immunohistochemistry and...
Minakem, the contract development and manufacturing division of Minafin, a Mont-Saint-Guibert, Belgium-based fine chemicals producer, plans to open a new closed-controlled environment high-containment production facility in August 2018 at the...
Marken, a Research Triangle Park, North Carolina-based provider of logistics and supply-chain services for clinical trial materials, is relocating its Chicago logistics hub into a new, larger facility near the Chicago airport.
The new full-service...
Recipharm, a Jordbro, Sweden-based contract development and manufacturing organization, has divested its rights, except in the US, for a potassium iodide product, ThyroSafe, to SERB SA, a Brussels, Belgium-headquartered specialty pharmaceutical...
Sarepta Therapeutics, a Cambridge, Massachusetts-based biopharmaceutical company focused on RNA-targeted therapeutics for rare neuromuscular diseases, has formed a long-term manufacturing partnership for gene-therapy with Brammer Bio, a Lexington,...
Recipharm, a Jordbro, Sweden-based contract development and manufacturing organization, has agreed to acquire Sanofi’s contract manufacturing business for respiratory products in Holmes Chapel, England for approximately $60 million.
The business...
Thermo Fisher Scientific has opened a US Precision Medicine Science Center (PMSC) in Cambridge, Massachusetts. The center offers access to technologies to help collaborators develop analytical workflows that generate precise molecular profiles of...
